FDA experts offer a big thumbs up for J&J’s flawed application to market esketamine for...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Feb 12, 2019 at 4:33 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    9,010
    Likes Received:
    2
    via J&J may have a deeply flawed application for its new/old drug to treat major depression, but the researchers who turned out to present the case for esketamine encountered a receptive audience of FDA experts on Tuesday.

    article source
     

play:inline;">